Research Article

QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562)

Volume: 5 Number: 3 September 1, 2018
EN

QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562)

Abstract

This research applied Quantitative Structure Activity Relationship (QSAR) technique in developing a Multiple-Linear Regression (MLR) model using Genetic Functional Algorithm (GFA) method in selecting relevant molecular descriptors from the structures of 24 C14-urea tetrandrine compounds. Firstly, the compounds were optimized at Density Functional Theory (DFT) level using Becke’s three-parameter Lee-Yang-Parr hybrid functional (B3LYP) with the 6-31G* basis set in the Spartan 14 Version 1.1.4 software. The molecular descriptors were calculated using Padel- software, and the results were divided in to training and test set. A model was built from the training set with internal validation parameter R2train as 0.910403. The external validation of the model was carried out using the test set compounds with validation parameter R2test as 0.6443 which passed the criteria for acceptability of a QSAR model globally. The coefficient of determination (𝑐𝑅2𝑝) parameter was calculated as 0.819296 which is greater than 0.5, this affirms that the generated model is robust. Furthermore, AST4p, GATS8v and MLFER are the descriptors in the model with positive mean effect of 0.089972855, 0.909814859 and 0.000212286 respectively. This study inferred that there will be positive influence on the inhibitory concentrations when the each descriptor value increases

Keywords

References

  1. 1. Lookward W. Leukemia (AML, CML, ALL and CLL). www.RN.ORG; ©RN.ORG®, S.A., RN.ORG®, LL; 2015. ISBN: 678-693-1-32.
  2. 2. Lozzio CB, Lozzio BB. Human Chronic Myelogenous Leukemia Cell-Line with Positive Philadelphia Chromosome. National Institute of Health. 1975; 45(1): 321–340.
  3. 3. Karimiani EG, Marriage F, Merritt AJ, Burthem J, Byers RJ, Day PJ. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Experimental Hematology. 2014; 42(3): 183-191
  4. 4. Fan Y, Lu H, An L, Wang C, Zhou Z, Feng F, Zhao Q. Effect of active fraction of Eriocaulon sieboldianum on human leukemia K562 cells via proliferation inhibition, cell cycle arrest and apoptosis induction. Environmental Toxicology and Pharmacology. 2016; 4(3):13-20.
  5. 5. Liu T, Liu X, Li WH. Tetrandrine, a Chinese Plant-Derived Alkaloid, Is a Potential Candidate for Cancer Chemotherapy, On Co-Target. 2016; 2(7):480100–480115.
  6. 6. Perkins R, Fang H, Tong W, Welsh WJ. Quantitative Structure-Activity Relationship Methods: Perspectives on Drug Discovery and Toxicology. 2003; 22(1): 1666–1679.
  7. 7. Lan J, Huang L, Lou H, Chen C, Liu T, Hu S, Yao Y, Song J, Luo J, Liu Y, Xia B, Xia L, Zeng X, Ben-David Y, Pan W. Design and Synthesis of Novel Tetrandrine Derivatives as Potential Anti-Tumor Agents against Human Hepatocellular Carcinoma. European Journal of Medicinal Chemistry. 2017 Sep; 3-4.
  8. 8. Becke AD. Becke’s three-parameter hybrid method using the LYP correlation functional. Journal of Chemical Physics. 1993; 98: 5648–5652.

Details

Primary Language

English

Subjects

Chemical Engineering

Journal Section

Research Article

Authors

Gideon Shallangwa This is me
Nigeria

Abdullahi Umar Bello This is me
Nigeria

Adamu Uzairu This is me
Nigeria

Paul Mamza This is me
Nigeria

Publication Date

September 1, 2018

Submission Date

September 6, 2018

Acceptance Date

December 25, 2018

Published in Issue

Year 2018 Volume: 5 Number: 3

APA
Mustapha, A., Shallangwa, G., Ibrahim, M. T., Bello, A. U., Ebuka, D. A., Uzairu, A., & Mamza, P. (2018). QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562). Journal of the Turkish Chemical Society Section A: Chemistry, 5(3), 1387-1398. https://doi.org/10.18596/jotcsa.457618
AMA
1.Mustapha A, Shallangwa G, Ibrahim MT, et al. QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562). JOTCSA. 2018;5(3):1387-1398. doi:10.18596/jotcsa.457618
Chicago
Mustapha, Abdullahi, Gideon Shallangwa, Muhammad Tukur Ibrahim, et al. 2018. “QSAR Studies on Some C14-Urea Tetrandrine Compounds As Potent Anti-Cancer Against Leukemia Cell Line (K562)”. Journal of the Turkish Chemical Society Section A: Chemistry 5 (3): 1387-98. https://doi.org/10.18596/jotcsa.457618.
EndNote
Mustapha A, Shallangwa G, Ibrahim MT, Bello AU, Ebuka DA, Uzairu A, Mamza P (September 1, 2018) QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562). Journal of the Turkish Chemical Society Section A: Chemistry 5 3 1387–1398.
IEEE
[1]A. Mustapha et al., “QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562)”, JOTCSA, vol. 5, no. 3, pp. 1387–1398, Sept. 2018, doi: 10.18596/jotcsa.457618.
ISNAD
Mustapha, Abdullahi - Shallangwa, Gideon - Ibrahim, Muhammad Tukur - Bello, Abdullahi Umar - Ebuka, David Arthur - Uzairu, Adamu - Mamza, Paul. “QSAR Studies on Some C14-Urea Tetrandrine Compounds As Potent Anti-Cancer Against Leukemia Cell Line (K562)”. Journal of the Turkish Chemical Society Section A: Chemistry 5/3 (September 1, 2018): 1387-1398. https://doi.org/10.18596/jotcsa.457618.
JAMA
1.Mustapha A, Shallangwa G, Ibrahim MT, Bello AU, Ebuka DA, Uzairu A, Mamza P. QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562). JOTCSA. 2018;5:1387–1398.
MLA
Mustapha, Abdullahi, et al. “QSAR Studies on Some C14-Urea Tetrandrine Compounds As Potent Anti-Cancer Against Leukemia Cell Line (K562)”. Journal of the Turkish Chemical Society Section A: Chemistry, vol. 5, no. 3, Sept. 2018, pp. 1387-98, doi:10.18596/jotcsa.457618.
Vancouver
1.Abdullahi Mustapha, Gideon Shallangwa, Muhammad Tukur Ibrahim, Abdullahi Umar Bello, David Arthur Ebuka, Adamu Uzairu, Paul Mamza. QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562). JOTCSA. 2018 Sep. 1;5(3):1387-98. doi:10.18596/jotcsa.457618

Cited By